EP
KURA icon

Elkfork Partners’s Kura Oncology KURA Stock Holding History

Elkfork Partners’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$20K Hold
1,298
– – ﹤0.01% 1031
2019
Q2 		$26K Sell
1,298
-1,188
-48% -$19.7K ﹤0.01% 1021
2019
Q1 		$41K Hold
2,486
– – ﹤0.01% 992
2018
Q4 		$35K Sell
2,486
-21,714
-90% -$288K ﹤0.01% 961
2018
Q3 		$424K Buy
24,200
+1,078
+5% +$20.7K 0.01% 643
2018
Q2 		$421K Sell
23,122
-2,068
-8% -$35K 0.01% 581
2018
Q1 		$472K Buy
+25,190
New +$490K 0.01% 540

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Elkfork Partners's KURA Position: Q3 2019 in Review

Elkfork Partners held its Kura Oncology (KURA) position steady in Q3 2019 at 1,298 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1031.

Elkfork Partners first reported a position in KURA in Q1 2018 and has held it in 7 quarters since. The position peaked at $472K in Q1 2018. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2019.

  • Elkfork Partners held 1,298 shares of Kura Oncology worth $20K as of Q3 2019.
  • Elkfork Partners left its Kura Oncology share count unchanged in Q3 2019.
  • Kura Oncology made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #1031 holding.
  • Elkfork Partners first reported a position in Kura Oncology in Q1 2018 and has held it in 7 quarters since.
  • Elkfork Partners's Kura Oncology position peaked at $472K in Q1 2018.
  • 116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.